Atlas Trials

(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds

Clinical trial NCT05364502 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05364502
Sponsor
Instylla, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Arterial Bleeding in Solid Organs and Peripheral Arteries
Start date
2022-12-12
Primary completion
2026-01-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.